Cellulitis and drugs of ingredients of carmustine (a real world drug study)


Summary:

Cellulitis is found among people who take drugs with ingredients of carmustine, especially for people who are male, 60+ old . This phase IV clinical study is created by eHealthMe based on reports of 6,477 people who have side effects when taking drugs with ingredients of carmustine from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Bicnu, Carmustine, Gliadel.


On Jun, 19, 2026

6,477 people reported to have side effects when taking drugs with ingredients of carmustine.
Among them, 24 people (0.37%) have Cellulitis


What is Cellulitis?

Cellulitis (infection under the skin) is found to be associated with 2,109 drugs and 2,337 conditions by eHealthMe. Check the latest studies of Cellulitis.

Number of reports submitted per year:

Could drugs with ingredients of carmustine cause Cellulitis?

Gender of people who have Cellulitis when taking drugs with ingredients of carmustine *:

  • female: 30 %
  • male: 70 %

Age of people who have Cellulitis when taking drugs with ingredients of carmustine *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 9.52 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 90.48 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Bone Marrow Conditioning Regimen: 13 people, 54.17%
  2. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 12 people, 50.00%
  3. Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 10 people, 41.67%
  4. Fever: 9 people, 37.50%
  5. Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 9 people, 37.50%
  6. Lymphoma (cancer that begins in immune system cells): 3 people, 12.50%
  7. Haematopoietic Stem Cell Mobilisation: 2 people, 8.33%
  8. Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 2 people, 8.33%
  9. Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 1 person, 4.17%
  10. Renal Amyloidosis (deposit of amyloid in kidney): 1 person, 4.17%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Cyclophosphamide: 12 people, 50.00%
  2. Cytarabine: 12 people, 50.00%
  3. Etoposide: 12 people, 50.00%
  4. Melphalan: 11 people, 45.83%
  5. Dexamethasone: 11 people, 45.83%
  6. Ifosfamide: 11 people, 45.83%
  7. Cisplatin: 11 people, 45.83%
  8. Prednisolone: 11 people, 45.83%
  9. Furosemide: 10 people, 41.67%
  10. Carboplatin: 10 people, 41.67%

Other side effects people have besides Cellulitis *:

You may use this to check any potential undetected side effects.

  1. Death: 15 people, 62.50%
  2. Tumor Lysis Syndrome: 10 people, 41.67%
  3. Myelosuppression (a decrease in the production of blood cells): 10 people, 41.67%
  4. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 10 people, 41.67%
  5. Drug Ineffective: 10 people, 41.67%
  6. Cardiac Tamponade (fluid accumulates in heart covering): 10 people, 41.67%
  7. Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 9 people, 37.50%
  8. Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 9 people, 37.50%
  9. Splenic Lesion (lesion on spleen): 8 people, 33.33%
  10. Hepatic Lesion: 8 people, 33.33%

* Approximation only. Some reports may have incomplete information.


How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related publications that referenced our studies

Related studies

Drugs with ingredients of carmustine, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on carmustine. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: